PCRI's Alex and Dr. Scholz go through patient questions left in our YouTube comments on the topics of Axumin vs. PSMA at low PSAs after surgery, the concept of micrometastases, and the future of mpMRI.
0:04 A patient has a PSA of 0.24 after radical prostatectomy and wants to know if the PSA is high enough for the recurrence to be detected on an Axumin PET scan, which was recommended by his physician. A support group leader suggested that a PSMA PET scan may be a better option.
1:25 What precisely are micrometastases (aka "micromets") and how are they related to "systemic" prostate cancer?
2:54 What is the future of mpMRI so that occult cancers will no longer be an issue? Is it a move to 5T? 7T? Is it new contrast agents like MT218?
Don’t know your stage? Take the quiz: Visit [ Ссылка ]
To learn more about prostate cancer visit [ Ссылка ]
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
#ProstateCancer #MarkScholzMD #Prostate
